Crystagen

COA by Freedom Diagnostics
Lot PH-CRY20605
COA 2603020051
Reported 03/2/2026
Verified

Average Purity

99.08%

Test Method

HPLC-MS

Identity

Pass

Endotoxin

Pass (<0.01 EU/mg)

Crystagen

Product

Crystagen

View full product details and compound information.

01

Sample Identification

LabFreedom Diagnostics
Document TypeCertificate of Analysis
COA Number2603020051
Accession NumberNumber
Search CodeProt2603020051
ClientProtide Health
ProductCrystagen
LotPH-CRY20605
Received Date09/08/2026
Reported Date03/2/2026

02

Purity & Quality Analysis

Purity (HPLC)

  • Average Purity 99.08%
  • Purity Vial 1 99.51%
  • Purity Vial 2 99.53%

Net Peptide Content

  • Net Peptide Average 21.67 mg
  • Net Peptide Vial 1 12.79 mg
  • Net Peptide Vial 2 12.61 mg

Identity & Appearance

  • Identity Pass
  • Appearance White Lyophilized Powder

Endotoxin (LAL)

  • Replicate 1 Pass (<0.01 EU/mg)
  • Replicate 2 Pass (<0.01 EU/mg)

03

Testing Methods & COA

Certificate of Analysis

Source COA scan, Crystagen lot PH-CRY20605

Mass Identification

CRYSTAGEN

Analysis Method

HPLC with UV Detection Coupled with Mass Spectrometry.

Average Purity Result

99.08%

Third-Party Verification

Third-party testing completed at Freedom Diagnostics, on 03/2/2026.

  • COA Number2603020051
  • Reported03/2/2026
  • LabFreedom Diagnostics

04

Test History for Crystagen

2 independent lab tests on file for this product.